New Requirement - CE-MS Interface

The Food and Drug Administration has forecasted a new requirement for a CE-MS interface, targeting the medical equipment and instrument manufacturing sector under NAICS code 334516. This procurement is intended to support advanced analytical capabilities critical to the agency’s mission, though specific technical specifications and performance expectations are not yet detailed. The opportunity is currently in a pre-solicitation phase with no formal solicitation number assigned, and no set-aside designation has been determined, indicating it may be open to all eligible contractors. The place of performance and office address information remain unspecified, suggesting flexibility in delivery location or remote implementation. Point of contact for this requirement is the Oc Acquisition Liaison, reachable at ocacquisitions@fda.hhs.gov, who serves as the primary liaison for inquiries. The contracting officer position has not yet been assigned, with details to be confirmed closer to the solicitation release. Interested parties should monitor the FDA’s opportunity forecast page for future updates, as the posting date indicates this is a forward-looking announcement with no immediate deadline. The lack of specific deliverables or timelines means potential vendors should prepare for a competitive and potentially complex acquisition process requiring technical expertise in capillary electrophoresis-mass spectrometry systems.